TAE Life Sciences (TLS)

TAE Life Sciences (TLS)

TAE Life Sciences (TLS) is a biologically-targeted radiation therapy company focused on developing novel treatments to improve the lives of patients with invasive, recurrent and difficult to treat cancers. Founded in 2017, TLS is the only company developing comprehensive target drugs and neutron technology product portfolio to enable next-generation boron neutron capture therapy (BNCT) as a first-line treatment for patients globally. The company has made a significant investment in developing a portfolio of new Boron-10 target drugs, with the goal of expanding the application of BNCT to new cancer types and to provide even better outcomes for indications historically treated with Boronophenylalanine (BPA), the only target drug currently utilized in BNCT.

Company details

19631 Pauling,Foothill Ranch,92610

Find locations servedoffice locations

Business Type:
Technology
Industry Type:
Clinical Services
Market Focus:
Nationally (across the country)
Year Founded:
2017

Contact supplier

Drop file here or browse